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ABSTRACT Little is known about longitudinal development of the peri-implant sub-
gingival microbiome and cytokine production as a new sulcus forms after dental im-
plant placement. Therefore, the purpose of this observational study was to evaluate
simultaneous longitudinal changes in the oral microbiome and cytokine production
in the developing peri-implant sulcus compared to control natural teeth. Four and
12 weeks after implant placement and abutment connection, a dental implant
and a natural tooth were sampled in 25 patients for subgingival plaque and gin-
gival crevicular fluid (GCF [around teeth] and peri-implant crevicular fluid [PICF]
around implants). DNA from plaque samples was extracted and sequenced using
Illumina-based 16S rRNA sequencing. GCF and PICF samples were analyzed using a
customized Milliplex human cytokine and chemokine magnetic bead panel. Beta di-
versity analysis revealed that natural teeth and implants had similar subgingival mi-
crobiomes, while teeth had greater alpha diversity than implants. At the genus level,
however, few differences were noted between teeth and dental implants over
12 weeks. Specifically, Actinomyces and Selenomonas were significantly elevated
around teeth versus dental implants at both 4 weeks and 12 weeks, while Coryne-
bacterium and Campylobacter were significantly elevated only at 4 weeks around
teeth. The only difference between PICF and GCF biomarkers was significantly ele-
vated granulocyte-macrophage colony-stimulating factor levels around teeth versus
dental implants at the 4-week visit. The subgingival microbiome and cytokine pro-
duction were similar between teeth and implants during early healing, suggesting
that these profiles are driven by the patient following dental implant placement and
are not determined by anatomical niche.
IMPORTANCE Dental implants are a common treatment option offered to patients
for tooth replacement. However, little is known regarding initial colonization of the
subgingival microbiome and simultaneous longitudinal cytokine production in hu-
mans during the early healing phase following implant placement. We report find-
ings from an in vivo study that assessed initial colonization of the subgingival micro-
biome and concomitant early cytokine production in a newly formed anatomical
space, namely, an implant sulcus. This approach may be useful in future interven-
tional studies to influence dental implant success. Our data showed that the subgin-
gival microbiome and cytokine profile were similar for control natural teeth and
dental implants at both 4 and 12 weeks after implant placement. These data sug-
gest that these profiles are driven by the patient and not by anatomical location
(i.e., tooth versus dental implant).
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Dental implants are a common option offered to patients for tooth replacement. Itis estimated that two to four million implants will be placed into individuals
annually in the United States by 2020 (1). Due to the rising trend of implant placement
for the management of partially edentulous patients, complications associated with
bone loss surrounding dental implants have become more prevalent (1). However, little
is known about the initial development and longitudinal progression of the peri-
implant subgingival microbiome (2). Past studies examining the initial subgingival
colonization patterns following dental implant placement have utilized DNA-DNA
hybridization (2, 3) to investigate the differences in select bacterial species in periodon-
tal and peri-implant pockets. Hybridization methods, as well as traditional methods for
microbial detection, including bacterial culturing techniques, are hindered by the
limited number of bacterial species that can be sampled for testing (4).
Unlike traditional microbial detection methods, next-generation sequencing is a
high-throughput method that allows for assessment of ecological diversity and for
identification of previously unknown or less abundant bacterial species (5, 6). Previ-
ously, multiplexed amplicon pyrosequencing revealed that the microbial peri-implant
communities differ from those of natural teeth (7). Specifically, these authors reported
that the microbial population within the peri-implant sulcus is less diverse as well as
unique from bacterial communities around natural teeth (7).
Next-generation sequencing has previously been used to evaluate the microbiota
surrounding natural teeth and dental implants (7, 8). However, to our knowledge, no
study has used this technology to evaluate the longitudinal colonization of the sub-
gingival oral microbiome in the newly developed sulcus surrounding recently placed
dental implants. Furthermore, the concomitant longitudinal progression of cytokine
production after dental implant placement has not been examined. Therefore, the
purpose of this observational study was to evaluate longitudinal changes in the oral
microbiome and cytokine production in the developing peri-implant sulcus, with
neighboring natural teeth as controls, during the first 12 weeks after dental implant
placement.
RESULTS
Study participants. The flow of patients from screening through the 12-week visit
is shown in Fig. 1. The first patient enrolled in the study on 7 July 2015, and the last
patient completed the study on 15 December 2016. Thirty-three patients enrolled in
the study, and eight individuals withdrew from the study at or before 4 weeks.
Twenty-five participants completed the study and provided subgingival plaque and
crevicular fluid samples at both 4- and 12-week visits. Of the 25 participants, only one
patient received antibiotic therapy during the study; this patient received a prescription
for amoxicillin (500 mg three times daily for 7 days) after the 4-week visit.
Table 1 includes baseline demographic and clinical findings. Participants had a mean
age of 60.5 years and were predominantly Caucasian (96%). Nineteen patients had a
history of periodontitis. The participants had mean whole-mouth probing depths of
2.5 mm. Bleeding on probing was noted at an average of 5.6% of sites, while suprag-
ingival plaque was present at an average of 29.0% of sites. The clinical findings for the
control teeth were similar to these whole-mouth data (Table 1).
Subgingival microbiome. A total of 100 subgingival plaque samples from 25
patients were sequenced, yielding 1.3 million sequences. The number of reads per
sample ranged from 25,651 to 70,637 with a mean of 47,821 reads and a standard
deviation of 7,769 reads. To standardize sequencing depth, 25,000 reads were sub-
sampled from each file, and rarefaction curves were generated. After the samples were
processed, operational taxonomic units (OTUs) were picked as described below in
Materials and Methods.
Stacked-bar plots were constructed to assess relative abundance at the genus level
for taxa with an average relative abundance of1% (Fig. 2). Those taxa with an average
of less than 1% were grouped together in “Others.” The most common taxonomic
groups found in the subgingival plaque samples from dental implants at 4 weeks were
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Streptococcus (20%), Fusobacterium (16%), Neisseria (12%), and Prevotella (9%), while the
most common taxa in the subgingival plaque samples from dental implants at
12 weeks were Streptococcus (22%), Fusobacterium (16%), Neisseria (8%), and Rothia
(7%).
Within the subgingival plaque samples from control teeth at 4 weeks, the most
common taxonomic groups were Streptococcus (22%), Fusobacterium (17%), Neisseria
(7%), and Prevotella (6%), while Fusobacterium (20%), Streptococcus (18%), Prevotella
(8%), and Veillonella (6%) were more common at 12 weeks.
Alpha diversity measurements (Fig. 3) revealed that control teeth had significantly
higher Shannon (P 0.007) and Chao1 (P 0.002) diversity indices and higher number
of observed OTUs (P 0.002) than dental implants did. However, the Simpson diversity
index did not differ between teeth and dental implants (P  0.127).
Principal-coordinate analysis plots (Fig. 4) of beta diversity, based on Bray-Curtis
dissimilarity matrix, did not show any obvious clustering between teeth and implants,
indicating that these two groups had similar subgingival microbiomes.
At the genus level, only a few differences were noted between teeth and dental
implants (Fig. 5). At 4 weeks, taxa that were significantly elevated around teeth versus
dental implants included Corynebacterium (P  0.006), Actinomyces (P  0.0007),
Campylobacter (P  0.0114), and Selenomonas (P  0.043). At 12 weeks, the following
taxa were significantly elevated around teeth versus dental implants: Selenomonas (P
0.046) and Actinomyces (P  0.012). Rothia appeared to be higher around dental
FIG 1 Diagram showing the flow of participants from screening through subgingival plaque and
crevicular fluid sample collection at 12 weeks. UTI, urinary tract infection.
Oral Microbiome and Cytokines around Healing Implants
November/December 2017 Volume 2 Issue 6 e00527-17 msphere.asm.org 3
implants relative to control teeth, although the difference was not significant (P 
0.0502).
Cytokines in GCF and PICF samples. For each sample, nine cytokines/immune
biomarkers were assayed. The results (Fig. 6A) showed that granulocyte-macrophage
colony-stimulating factor (GM-CSF) was significantly elevated in gingival crevicular fluid
(GCF) at 4 weeks relative to peri-implant crevicular fluid (PICF) (P  0.00786). No other
differences were noted between GCF and PICF for any of the other cytokines or
chemokines at 4 or 12 weeks (Fig. 6).
Subgroup analyses for cytokines and subgingival microbiome. Interleukin-10
(IL-10) was statistically significantly elevated in PICF samples from failed implants (n 
4) than in healthy implants (n  14) at 12 weeks (P  0.0346) (Fig. 7A). No other
differences in cytokine levels were noted between PICF samples from failed implants
versus healthy implants at 4 or 12 weeks (data not shown). No differences in cytokine
levels were noted between PICF samples taken from around healthy implants (n  14)
versus samples from patients with peri-implant disease (n  11) (data not shown).
At 4 weeks, the only statistically significant difference at the genus level between
healthy implants and failed implants was elevated Oribacterium around failed implants
(P  0.0244) (Fig. 7B), and at 12 weeks, the only statistically significant difference at the
genus level between healthy implants and failed implants was elevated Parvimonas
around failed implants (P  0.0131) (Fig. 7C). No differences at the genus level were
noted between healthy implants (n  14) and implants in patients with peri-implant
disease (n  11) other than elevated Oribacterium at 4 weeks around implants in
patients with peri-implant disease (P  0.002); however, the average relative abun-
dance of this organism was less than 0.5% (data not shown).
DISCUSSION
When a dental implant is placed and an abutment is connected, an open niche is
created within the oral environment. Specifically, the new sulcus that forms is initially
free of bacteria or, as described by Quirynen et al. (2), a “pristine” pocket is formed. As
such, recently placed dental implants provide a unique opportunity to study initial
subgingival colonization. Using Illumina-based 16S rRNA sequencing, the current study
TABLE 1 Baseline sociodemographic data and clinical characteristics of study patients
Baseline sociodemographic factor or clinical characteristic
No. of patients (%) or
parameter value
Baseline sociodemographics
Age (yr) (mean  SD) 60.5  13.9
Male 14 (56.0)
Female 11 (44.0)
Race
American Indian or Alaskan native 1 (4.0)
Asian 0
Black or African American 0
White 24 (96.0)
Other 0
Clinical characteristics
Periodontitis diagnosis
None 6 (24.0)
Mild 4 (16.0)
Moderate 11 (44.0)
Severe 4 (16.0)
Probing depth (mm) (whole mouth) (mean  SD) 2.5  0.4
Bleeding on probing (whole mouth) (% of sites) 5.6
Supragingival plaque (whole mouth) (% of sites) 29.0
Estimated probing depth of implantsa (mm) (mean  SD) 1.2  0.5
Probing depth (mm) (control teeth) (mean  SD) 2.4  0.3
Bleeding on probing (control teeth) (% of sites) 4.0
Supragingival plaque (control teeth) (%) 30.0
aThe estimated probing depth of implants is the gingival thickness minus 1.4 mm.
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compared the composition of the subgingival microbiome around newly placed dental
implants with that from nearby control teeth. The results showed that the microbiomes
in both locations were similar as early as 4 weeks after implant placement. However,
two indicators of microbiome diversity, richness and evenness, were decreased around
dental implants compared to control teeth. Likewise, cytokine production was generally
comparable around newly placed dental implants and control teeth, suggesting that
the host responses to the subgingival microbiota were similar at these two sites.
On the basis of relative taxonomic abundance, Streptococcus and Fusobacterium
represented nearly 40% of the microbiome for both implants and control teeth at
4 weeks and 12 weeks. Furthermore, Prevotella and Neisseria were also among the most
common taxa observed both around implants and control teeth. These OTUs were
likewise dominant in implant samples, as previously described by Zheng et al. (9) using
similar sequencing methods. In contrast, Schaumann et al. (10) reported that Rothia,
Streptococcus, and Porphyromonas were the most abundant taxa in the implant sub-
gingival microbiome, while Prevotella, Streptococcus, and TG5 were the predominant
subgingival microbiota around teeth. However, direct comparisons between dental
implant microbiome studies are very difficult due to the different microbial analysis
methods used, nonstandardized study designs, various patient inclusion/exclusion
criteria, and unspecified implant history with respect to when implants were placed
prior to the beginning of the study (11).
Dental implants in our study showed lower microbial diversity than control teeth, in
agreement with other investigations (7, 12–14). It is possible that the lower microbial
FIG 2 Genus-level composition of subgingival microbiome around implants and teeth for combined
4-week and 12-week subgingival plaque samples (n  50 for each) and for 4-week and 12-week visits
separately for implants and teeth (n  25 for each). Genera present at an average relative abundance
of1% are included in the stacked-bar plot and are listed on the right with their respective color coding.
Taxa with an average relative abundance of 1% are grouped in “Others.”
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diversity around dental implants in our observational study was due to the short-term
follow-up after implant placement. However, in each of the above-referenced publica-
tions, although the number of years since implant placement was unknown, the
implants were not newly placed and the microbial diversity was significantly lower in
the subgingival environment around implants than around teeth. Comparing specific
taxa between implants and teeth in our study, there were few differences in genera
between implants and teeth at either 4 or 12 weeks. At 4 weeks, Corynebacterium,
Actinomyces, Selenomonas, and Campylobacter were elevated around teeth versus
implants. At 12 weeks, only Actinomyces and Selenomonas were more abundant around
teeth. It is possible that, with further maturation of the subgingival microbiota, even
these remaining differences would dissipate over time, resulting in further convergence
of the microbiomes.
The source of the newly formed subgingival microbiota around dental implants is
not well understood. However, saliva is a likely reservoir and conduit to transport
microorganisms from the rest of the dentition and from nondental sites such as the
tongue, buccal mucosa, and tonsils. It is interesting to note that all study participants
rinsed with 0.12% chlorhexidine gluconate twice daily for 1 week following implant
surgery. Chlorhexidine gluconate has been shown to significantly reduce supragingival
dental plaque formation, even in the absence of brushing (15). However, rinsing with
FIG 3 (A) Shannon and Simpson diversity indices comparing implants to teeth for combined 4-week and
12-week subgingival plaque samples. (B) Chao1 diversity index comparing implants to teeth for com-
bined 4-week and 12-week subgingival plaque samples. (C) Number of OTUs comparing implants to
teeth for combined 4-week and 12-week subgingival plaque samples. There were 50 samples for both
implants and teeth. Values that are significantly different (P  0.01) are indicated by an asterisk. Values
that are not significantly different (NS) are indicated.
FIG 4 Principal-coordinate analysis of beta diversity based on Bray-Curtis distance for combined 4-week
and 12-week subgingival plaque samples (50 samples for both implants and teeth). No evidence of
clustering was noted between implants and teeth. PC1, principal coordinate 1.
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chlorhexidine likely does not result in this medicament reaching the subgingival
environment. Furthermore, chlorhexidine gluconate rinsing does not eliminate suprag-
ingival plaque formation (15). Therefore, this postoperative regimen does not prevent
transfer of microorganisms from other oral and dental sites.
When comparing crevicular fluid cytokines between dental implants and control
teeth at 4 and 12 weeks, the overall levels were very similar. However, we noted
elevated GM-CSF levels in the crevicular fluid around teeth versus dental implants at
4 weeks. GM-CSF is known to recruit circulating neutrophils, monocytes, and lympho-
cytes (16). In the current study, control teeth sites were scaled subgingivally at the
baseline dental implant placement appointment. The patients in our study refrained
from brushing the newly placed dental implants and control teeth for 1 week, although
the participants used, as mentioned above, a plaque-reducing mouth rinse during that
time frame. It is quite likely that recolonization of the subgingival microbiota at these
control tooth sites triggered a localized host response, resulting in elevated GM-CSF to
recruit inflammatory cells.
There are few published studies assessing GM-CSF formation around dental im-
plants. A recently published experimental gingivitis study examined cytokines, includ-
ing GM-CSF, around existing implants which had been present for at least 1 year in
patients who had refrained from brushing both dental implants and teeth for 3 weeks
(17). At day 21, IL-1, GM-CSF, tumor necrosis factor alpha (TNF-), and interferon
gamma (IFN-) were significantly higher in GCF than PICF. Although in our study, we
FIG 5 (A and B) Differences at the genus level between teeth (n  25) and implants (n  25) at 4 weeks
(A) and 12 weeks (B). Values that are significantly different are indicated by asterisks as follows: *, P 
0.05; **, P  0.01; ***, P  0.001.
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did not observe differences in IL-1 and TNF- between GCF and PICF samples, the
patient populations and study designs were different in the studies, as noted above. It
is possible that no other cytokine or chemokine differences were observed for dental
implants and control teeth in our study due to the timing or frequency of crevicular
fluid sample collection, as our sampling may have missed transient increases or
decreases in cytokine levels.
Although IL-10 is primarily recognized for its anti-inflammatory properties, this
cytokine can have either favorable or unfavorable effects on the host depending on the
FIG 6 (A) Chemokines in GCF and PICF at 4 weeks (n  25) and 12 weeks (n  25). The GM-CSF value
in GCF was statistically significantly different (P  0.01) from the GM-CSF value in PICF as indicated by
the asterisk. No other statistically significant differences were noted for the GM-CSF and MCP-1 values
between PICF and GCF. (B) Inflammatory cytokines in GCF and PICF at 4 weeks (n  25) and 12 weeks
(n 25). No statistically significant differences in these inflammatory cytokine levels were noted between
PICF and GCF at either time point. (C) Anti-inflammatory cytokines in GCF and PICF at 4 weeks (n  25)
and 12 weeks (n 25). No statistically significant differences were noted between PICF and GCF at either
time point.
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nature of the bacterial infection or the levels of IL-10 produced (18). In subgroup
analyses, IL-10 was elevated in failed implants versus healthy implants at 12 weeks, in
agreement with Ata-Ali et al. (19). In contrast, Casado et al. (20) showed that IL-10
concentrations were lower in patients with peri-implantitis than in patients with
healthy implants, while other studies have reported no differences (21, 22). The findings
in our study suggest that elevated IL-10 reflects an attempt by the host to limit the
development of an inflammatory response around failed implants.
When the microbiota around failed implants was examined, we observed that
Parvimonas, a genus that includes the periodontal pathogen Parvimonas micra, and
Oribacterium, a genus not associated with periodontitis (23), were elevated relative to
healthy implants. Koyanagi et al. (8) and Tamura et al. (24) similarly reported that
P. micra, a member of the orange complex (25), was detected in patients with
peri-implantitis. The microbiome and cytokine findings in our subgroup analyses
should be interpreted with caution due to the small sample sizes of each subgroup and
the exploratory nature of these analyses.
One limitation of this study was the short duration. The study duration was only
12 weeks because the plan was for patients to proceed with implant restoration shortly
thereafter, which would have likely influenced the subgingival microenvironment.
However, regarding fluctuations in the oral microbiome over time, recent evidence
indicates that 83% of oral microbial samples taken a year after initial sampling could be
confidently traced back to the source subject; indeed, phylogenetic diversity remained
relatively stable over time within individuals over 1 year compared to interindividual
variation (26). However, strengths of our study include evaluation of the entire sub-
gingival microbiome rather than targeted organisms and simultaneous evaluation of a
panel of cytokines. Indeed, to our knowledge, this is the first study to examine both the
subgingival microbiota and host response during early dental implant healing. In
addition, we propose that this novel experimental approach can be used as a human
in vivo model for other investigations of initial subgingival colonization and early
cytokine production in a newly formed anatomical space, namely, an implant sulcus.
The mouth is easily accessible for simultaneous collection of subgingival plaque
samples for microbial analysis and crevicular fluid samples for cytokine detection
around dental implants. With this approach, initial subgingival colonization and cyto-
kine production can be studied in patients with various systemic conditions (e.g., poorly
controlled diabetes and rheumatoid arthritis) which have been shown to impact
FIG 7 (A) IL-10 in PICF samples from implant sites. PICF samples were taken from healthy implant sites
(H-PICF) (n  14) and failed implant sites (F-PICF) (n  4) at 4 weeks and 12 weeks. (B and C) Difference
at the genus level at healthy implant sites (n  14) versus failed implant sites (n  4) at 4 weeks (B) and
12 weeks (C). *, P  0.05.
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periodontal (27, 28) and implant (29, 30) health and in smokers, as smoking is a major
environmental risk factor for both periodontitis (31) and implant failure (32). Further-
more, this model can be used to study the impact of pharmaceutical interventions to
potentially alter initial subgingival microbiome formation and early cytokine produc-
tion and, thereby, possibly influence implant success.
In summary, in this 12-week observational study, the subgingival microbiome and
cytokine production were similar in teeth and dental implants during early implant
healing. These data suggest that initial subgingival microbial colonization and cytokine
production are driven by the patient and are not determined by anatomical niche (i.e.,
implant versus tooth). Furthermore, future studies can potentially use this human in
vivo model to examine initial subgingival microbiota development and simultaneous
cytokine production following dental implant placement in patient populations with
various systemic diseases and environmental risk factors for implant failure.
MATERIALS AND METHODS
Study participants. Approval for this observational study was obtained from the University of
Nebraska Medical Center (UNMC) Institutional Review Board (protocol number 202-15-EP). Partially
edentulous patients were enrolled from the UNMC College of Dentistry’s Department of Surgical
Specialties, Section of Periodontics. Twenty-five patients completed the 12-week study and provided
both subgingival plaque and crevicular fluid samples from a recently placed dental implant and a control
tooth.
Patients in good general health receiving at least one dental implant, including the placement of a
transmucosal healing abutment, were potentially eligible for this study. Exclusion criteria for study
enrollment were as follows: (i) pregnancy; (ii) diabetes; (iii) HIV infection; (iv) currently taking systemic
immunosuppressant medications; (v) currently taking any bisphosphonates; (vi) antibiotics in the previ-
ous 3 months; (vii) patient self-report of smoking in the previous 6 months; (viii) requiring preoperative
prophylactic antibiotics; (ix) fewer than 15 teeth present; (x) under 19 years of age. All participants
provided written informed consent before study enrollment.
Individuals enrolled in this study had already decided to pursue implant treatment prior to being
approached regarding study participation. All patients participated in the College of Dentistry’s implant
screening and planning process. Patients received a comprehensive periodontal examination and were
screened for dental implant placement by a periodontal resident. The patient’s periodontitis case
definition was determined based on measurements of probing depths and clinical attachment loss
according to Eke et al. (33). Bleeding on probing and plaque score were also recorded. A prosthodontist
then evaluated the restorability of edentulous sites with dental implants. Finally, members of the
restorative and surgical team met prior to the placement of the dental implant to discuss any relevant
treatment considerations. These considerations included systemic patient health factors, restorative
considerations, and periodontal health considerations. No patients in this study required active peri-
odontal treatment.
Day of implant placement. Patients were screened for study inclusion on the day of implant
placement on a rolling admission basis. Medical history was reviewed prior to each implant procedure.
Sociodemographic data were collected and included age, gender, race, and ethnicity. All implants were
placed at posterior sites (premolar or molar) with the exception of one implant placed at an anterior
(cuspid) location. A tooth was selected for evaluation as a control within the same quadrant as the
implant site. The control tooth was the first available tooth mesial to the implant site and was separated
from the implant by at least one natural tooth in order to avoid possible influence from the adjacent
developing implant sulcus (34).
Probing depths, bleeding on probing, and supragingival plaque were recorded for the control tooth.
Subgingival scaling was completed presurgically on the control tooth chosen to be sampled. During the
implant surgery, flaps were reflected, and gingival thickness was measured from six different sites
surrounding the implant with a Marquis probe (Hu-Friedy, Inc., Chicago, IL) (2). A transmucosal healing
abutment was used for all patients. Implants were manufactured by Nobel Biocare (Yorba Linda, CA); root
form, tapered implants were placed. Patients were instructed to avoid brushing at or near the surgical
site for 1 week. All patients were prescribed and instructed to gently rinse with 0.12% chlorhexidine
gluconate for 30 s twice per day for 1 week (2). Postoperative acetaminophen or hydrocodone with
acetaminophen was advised for postoperative analgesia.
Four-week GCF, PICF, and subgingival plaque sample collection. Medical history and exclusion
criteria were reviewed for patients returning for the 4-week postoperative and sample collection visit. All
patients were assessed for any signs of infection or failure of implant osseointegration at this appoint-
ment.
Crevicular fluid samples, followed by subgingival plaque samples, were collected at the dental
implant and control tooth sites on patients who continued to be eligible for study participation. Prior to
crevicular fluid and subgingival plaque sample collection, supragingival plaque was removed around the
implant abutment and control tooth by scaling. The implant and control tooth were isolated using cotton
rolls and gently air dried. Crevicular fluid samples were then collected by inserting filter paper strips
(Periopaper; Proflow, Amityville, NY), until slight resistance was felt, into the mesiobuccal and mesiolin-
gual peri-implant and tooth sulci for 30 s. The two peri-implant crevicular fluid (PICF) samples for the
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implant were placed into a single microcentrifuge tube on ice beside the dentist’s chair and frozen at
80°C within 10 min of collection. Likewise, the same procedure was followed for the two gingival
crevicular fluid (GCF) samples taken from the control tooth.
Peri-implant plaque samples were collected by inserting four separate sterile endodontic paper
points (Henry Schein medium absorbent points; Melville, NY) into the mesial, distal, buccal, and lingual
sites (i.e., circumferentially around the implant) for a period of 10 s each. Subgingival plaque samples
collected from around the dental implant were pooled in a single microcentrifuge tube and frozen at
80°C within 10 min of collection. The same procedure was followed for the plaque samples taken from
the control tooth. GCF, PICF, and subgingival plaque samples remained frozen at 80°C until analysis.
Twelve-week GCF, PICF, and subgingival plaque sample collection. Twelve weeks after the initial
implant placement, patients returned, and the same protocol was performed as described above for the
4-week sample collection appointment. All plaque, GCF, and PICF samples at both 4-week and 12-week
visits were collected by the same investigator (P. G. Johnson).
DNA extraction of plaque samples. DNA extraction was performed by the method of Martinez et
al. (35) with slight modifications. Briefly, 200 l of ice-cold phosphate-buffered saline (PBS) was added to
tubes containing the paper points and the tubes were vortexed for 15 min. Next, 750 l of lysis buffer
and 20 mg/ml of lysozyme were added to the tubes, and the samples were then transferred into bead
beating tubes containing 300 mg of disruption beads (0.1 mm; Research Products International Corp.,
Mount Prospect, IL). The samples were incubated for 15 min in a 37°C water bath. Then, 85 l of 10%
SDS solution and 40 l of proteinase K (15 mg/ml) were added to the tubes, and the samples were
incubated for 15 min in a 60°C water bath. Five hundred microliters of phenol-chloroform-isoamyl
alcohol (25:24:1) was added to each tube, and the samples were homogenized using a mini-bead beater
(BioSpec Products, Bartlesville, OK) for 2 min at high speed. The samples were then centrifuged at
10,000  g for 5 min, and the top aqueous layer was extracted. This extraction was repeated twice using
500 l of phenol-chloroform-isoamyl alcohol (25:24:1) and twice using 500 l chloroform-isoamyl alcohol
(24:1). Overnight ethanol precipitation was used to recover DNA, and the DNA pellets were dissolved in
100-l portions of Tris-HCl buffer (10 mM; pH 8.0). DNA was quantified using a NanoDrop ND-1000
spectrophotometer (NanoDrop Technologies, Inc., Wilmington, DE) and stored at 20°C.
Sequencing and microbial community analysis. The DNA samples were submitted to Neogen
GeneSeek Operations (Lincoln, NE) for 16S rRNA paired-end sequencing using the Illumina MiSeq system.
The primers used were 515F (F stands for forward) (5=-GTGCCAGCMGCCGCGGTAA-3=) and 806R (R stands
for reverse) (5=-GGACTACHVGGGTWTCTAAT-3=), flanking the 515 and 806 region. Barcodes were at-
tached to the 806R primers, and 2  250 reads were sequenced on the Illumina MiSeq system.
Quantitative Insights into Microbial Ecology (QIIME) was used to analyze the microbial community (36).
Briefly, sequences were demultiplexed, and barcodes were removed prior to analysis. The sequences
were checked for quality using FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) and
sequences with a phred score of less than 20 were trimmed with TrimGalore (https://www.bioinformatics
.babraham.ac.uk/projects/trim_galore/). Sequences with a maximum length of 255 bp were merged
using PANDAseq (37) with a threshold score of 0.9. Reads with ambiguous nucleotides were removed
during the merge. Using subsampled open reference operational taxonomic unit (OTU) picking in QIIME
(38), the sequences were first referenced at a 97% similarity against the Human Oral Microbiome
Database (HOMD 16S rRNA RefSeq V13.2). Sequences that did not hit the database were clustered into
OTUs at a 97% sequence similarity using Uclust, followed by PyNAST alignment. Taxonomy was assigned
using QIIME’s Uclust-based Consensus Taxonomy Assigner. In QIIME, ChimeraSlayer was used to check
for chimeric sequences after OTU picking. QIIME was subsequently used to analyze both alpha and beta
diversities of the oral microbial community. Specifically, Shannon index, Simpson index, Chao1 richness
estimator, and the number of observed OTUs were used to determine alpha diversity, while beta diversity
was visualized using principal-component analysis (PCoA) based on Bray-Curtis distance (36).
GCF and PICF cytokine determination. At the time of analysis, each pooled GCF and PICF sample
was eluted using 60 l of 1 PBS by gently agitating the samples on a rocker plate for 1 h at 4°C. Aliquots
for interleukin-1 receptor antagonist (IL-1ra) assessment were diluted at 1:100 so that the cytokine levels
were not above the upper limit of the standard curve. Aliquots to determine the amounts of the other
cytokines present in GCF or PICF were not diluted. Cytokine and chemokine concentrations were
measured using a customized human cytokine and chemokine magnetic bead panel (Milliplex MAP kit;
Millipore, Billerica, MA), and a MAGPIX instrument and software (Luminex Corporation, Austin, TX) per the
manufacturers’ recommendations. Nine analytes were measured: interleukin-1 (IL-1), IL-1 receptor
antagonist (IL-1ra), IL-4, IL-6, IL-8, IL-10, granulocyte-macrophage colony-stimulating factor (GM-CSF),
monocyte chemoattractant protein 1 (MCP-1), and tumor necrosis factor alpha (TNF-). The amounts of
cytokines are reported in picograms per 30-s sample.
Statistical analyses. (i) Subgingival microbiome. Statistical analyses were performed using R
version 3.3.2 (R Core Team, 2016, R Foundation for Statistical Computing, Vienna, Austria), QIIME, linear
discriminant analysis effect size (LEfSe), and analysis of composition of microbiomes (ANCOM) to
compare control teeth (n  25) and dental implants (n  25) at 4 and 12 weeks. In QIIME, P values were
obtained from nonparametric two-sample t tests using Monte-Carlo permutations to compare alpha
diversity measures of control teeth and dental implants.
In R, nonparametric significance tests, permutational multivariate analysis of variance (PERMANOVA),
and analysis of similarities (ANOSIM) based on Bray-Curtis dissimilarity coefficients were used to compare
community composition between groups. Differential taxonomic groups between control teeth and
dental implants were identified using four differential abundance analysis models: RF (random forest)
and classification tree analysis in R, LEfSe to compute linear discriminant analysis (LDA) effect size (39),
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and ANCOM (40). Top hits were identified as the taxa that were successfully differentiated in at least two
models, and the relative abundance of the top hits was compared between control teeth and implants
using the pairwise Wilcoxon signed-rank test. The differences in taxa between the groups were
considered significant at P  0.05 after Bonferroni’s correction.
(ii) GCF and PICF cytokine determination. All statistical analyses were conducted using the R
software, version 3.3.2 (R Core Team, 2016, R Foundation for Statistical Computing, Vienna, Austria).
Statistical modeling was done using the lmerTest package using the lmer function (41). Comparisons
were made between the control teeth (n  25) and dental implants (n  25) at 4 and 12 weeks.
Cytokine concentrations were log transformed. Then, comparisons between PICF and GCF were
performed using a generalized linear mixed-model approach that included a parametric analysis of
variance (ANOVA) (i.e., log10 transformed cytokine concentration) with the group (implant versus control
natural tooth) as the fixed effect and the site by patient as the random intercept. Specifically, compar-
isons between PICF versus GCF over time were performed using the group [i.e., interaction between two
anatomical sites for each of the 25 patients with two time points, 4 and 12 weeks] as the fixed effect and
the site by patient as the random effect [i.e., this term assumed that the effect of patient is random and
that both the intercept and slope of site depended on each patient]. Thereafter, all posthoc testing was
done using Tukey’s test adjusted for multiple comparisons using Bonferroni’s correction. Significant
differences across groups were considered if P  0.05.
(iii) Subgroup analyses. Of the 25 implants that were sampled 4 weeks and 12 weeks after
placement, 14 were entirely healthy at 12 weeks (i.e., no evidence of inflammation or alveolar bone loss),
while 11 implants had signs of peri-implant disease (evidence of inflammation or alveolar bone loss), four
of which failed at 12 weeks and were removed.
The following subgroup analyses were performed with respect to the subgingival microbiome and
crevicular fluid: healthy implants (n  14) versus implants with evidence of peri-implant disease (n  11)
and healthy implants (n  14) versus failed implants (n  4). For the subgingival microbiome, the same
statistical analyses as outlined above, for the entire study population, were performed with the exception
of using the unpaired Wilcoxon test to compare the top differential taxa of the subgroup comparisons.
Crevicular fluid cytokine and chemokine comparison for healthy implants (n  14) and implants that
failed at 12 weeks (n  4) and comparison between healthy implants and implants with evidence of
peri-implant disease (n  11) were done via a linear mixed-model approach using the group as the fixed
effect and the patient as the random effect (i.e., random intercept by patient).
Accession number(s). Sequences have been deposited in the NCBI database under BioProject
accession number PRJNA417321.
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